In order to evaluate the Ndi1 protein as a potential therapeutic agent for PD, it is a prerequisite to investigate whether the Ndi1 protein is capable of protecting the nigrostriatal system against Parkinsonian symptoms in rotenone rat models of PD. The gene discussed is AVPR2; the disease is Parkinson disease.